Skip to main content
Clinical Trials/NCT05341271
NCT05341271
Unknown
N/A

The Effect of Digital Reminiscence Therapy on People With Mild and Moderate Dementia: A Randomized Controlled Trial.

National Taipei University of Nursing and Health Sciences1 site in 1 country186 target enrollmentJanuary 21, 2022
ConditionsDementia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dementia
Sponsor
National Taipei University of Nursing and Health Sciences
Enrollment
186
Locations
1
Primary Endpoint
Cornell Scale for Depression in Dementia; CSDD
Last Updated
4 years ago

Overview

Brief Summary

In the post-epidemic era, it is necessary to develop support programs for families with dementia in empirical care. The reminiscence therapy was adopted by patients with mild and moderate dementia those intervention have had good memory stimulation and emotional support effects in the previous studies. However, the application of digital reminiscence therapy that cross spatial and geographic constraints, but related research still has limitations on the knowledge of this topic.

To use the official Line @ account as a media platform to develop a digital reminiscence group program (DRG), and to investigate the effects of mobile-application-based DRG on the psychoneurological symptoms, depression, life meaning and burden of family caregiver in people with mild and moderate dementia (PMMD).

Detailed Description

In the post-epidemic era, it is necessary to develop support programs for families with dementia in empirical care. The reminiscence therapy was adopted by patients with mild and moderate dementia those intervention have had good memory stimulation and emotional support effects in the previous studies. However, the application of digital reminiscence therapy that cross spatial and geographic constraints, but related research still has limitations on the knowledge of this topic. To use the official Line @ account as a media platform to develop a digital reminiscence group program (DRG), and to investigate the effects of mobile-application-based DRG on the psychoneurological symptoms, depression, life meaning and burden of family caregiver in people with mild and moderate dementia (PMMD). This will be the first digital reminiscence group constructed specifically for family's people with mild and moderate dementia in our country. The investigators expected to have a positive effect. It can be used as a reference for the development of empirical care programs for family caregivers with PMMD in the community.

Registry
clinicaltrials.gov
Start Date
January 21, 2022
End Date
July 31, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chia Jung Hsieh

Ph.D., RN, Associate Professor

National Taipei University of Nursing and Health Sciences

Eligibility Criteria

Inclusion Criteria

  • The conditions for accepting cases for families with dementia are as follows:
  • Family caregivers must meet the following conditions:
  • ①Age 20 years old or above
  • ②Have experience in caring for the dementia case in the past year, and live together
  • Have a smart phone and have experience in using line APP
  • Dementia patients must meet the following conditions:
  • Those who currently live at home and regularly go to the Rizhao Center to participate in activities ②Patients with dementia (Alzheimer's disease) diagnosed by a physician with DSM 5 or in line with NINCDS/ADRDA, their CDR score is 1\~2 points ③ Those who have a clear consciousness, can express in Chinese and Taiwanese, or communicate with others in words without hindrance ④ Those who have normal vision and hearing, and can operate digital mobile phones or tablets

Exclusion Criteria

  • The exclusion criteria for families with dementia are:
  • The exclusion conditions for family caregivers are:
  • A history of mental illness diagnosed by a psychiatrist, such as major depression ② Those who are not of their own nationality.
  • The exclusion conditions for patients with dementia are:
  • Confusion or delirium ② Dementia cases who will be referred to long-term care institutions or nursing homes within one month.

Outcomes

Primary Outcomes

Cornell Scale for Depression in Dementia; CSDD

Time Frame: One month after the end of the intervention (T2)

For patients with dementia who cannot communicate properly with others through oral expressions, making it difficult to identify their depressive symptoms, the application of this observation scale can effectively and appropriately detect depression in the elderly with cognitive impairment. The Kappa value of the two-week rater-ask agreement reliability (inter-rater agreement) was .43, indicating that all items were significantly stable; and the Cronbach's alpha of the internal consistency reliability was .84, this scale The source of the assessment was primarily asking the patient's family caregiver.

Purpose in Life Test:

Time Frame: One month after the end of the intervention (T2)

This scale is used to assess the extent to which the elderly perceive the meaning and purpose of their life. There are 9 questions in two aspects (personal value and success of children and grandchildren), which are answered on a four-point scale. Among them, questions 5 and 6 are reverse questions. The total score ranges from 9 to 36 points. The higher the total score, the more positive and meaningful the subject feels about life. This scale has content validity completed by experts and scholars, and the internal consistency Cronbach α value of the scale is .75. After factor analysis, the explained variation of the two factors of shaping can reach 54.4%, indicating that this scale has good performance. reliability and validity.

Mini-Mental State Examination; MMSE

Time Frame: One month after the end of the intervention (T2)

The content of the test includes orientation, immediate memory, recent memory, concentration or attention, etc. The full score is 30 points. It is currently used in clinical and research, and is often used for cognitive evaluation of the elderly, and is widely used.

Neuropsychiatric Inventory, NPI

Time Frame: One month after the end of the intervention (T2)

The content of the scale is to ask primary caregivers about new behaviors or changes in behavior since the onset of the patient, whether in the past four weeks or within a specified period of time. NPI includes 12 psycho-behavioral symptom items. The scoring method first uses screening questions to determine whether there is a change in behavior, then in-depth understanding of the changed behavior, and finally determines the frequency, severity and caregiver distress of the behavior according to each behavior degree. In terms of reliability and validity of the scale, the Cronbach's alpha for Chinese was 0.76, and the test-retest reliabilities of severity frequency and caregiver stress in the scale were 0.82, 0.85 and 0.79 respectively. It also has good reliability and validity (Fuh, Liu, Mega, Wang, \& Cummings, 2001), and the assessment source of this scale is mainly asking the family caregivers of the patients.

Study Sites (1)

Loading locations...

Similar Trials